In this trial, 17,604 patients were enrolled to receive semaglutide 2.4 mg weekly or placebo and followed for approximately 36 months
Kang YM, Punov V, Lim S, Nauck MA
Chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) Reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes and known heart disease
To date, the GLP-1 Supply Tracker has generated more than 50,000 crowdsourced shortage reports and thousands of supply reports, data which Ro has shared with the FDA
Prices will rise to $199 a month for certain doses after April 15, 2026
Not everyone needs every peptide, and staggered implementation helps identify the minimum effective stack